Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT00615433
Status:
COMPLETED
Last Update Posted:
2015-06-12
First Post:
2008-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1050231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None